NUS News and Press, Nu Skin Enterprises Inc. From 07/17/25

2025-07-17 12:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2025 results after the market closes on Thursday, Aug. 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will d...

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a relaunch that merges high-performance skincare with planet-friendly innovation. The refreshed line now features upgraded, more sustainable pack...

2025-06-25 03:55:12 ET On paper, it's not terribly difficult to make the case for Nu Skin Enterprises ( NUS ). The valuation looks incredibly cheap: on a trailing twelve-month basis, NUS stock trades at 2.5x EV/EBITDA and about 5.6x free cash flow. Revenue streams outside the legacy...

2025-06-06 10:45:52 ET Intro Our most recent commentary on Nu Skin Enterprises, Inc. ( NUS ) was in May 2022, when we backed the company's transition strategy to eventually return the direct-selling beauty & wellness company to growth. Our optimism, however, came with a ...

Nu Skin Enterprises (NUS: NYSE) today announced the appointment of James Winett, a managing member of SIZE Advisory Group, to the company’s board of directors. He was elected by shareholders at the annual shareholder meeting for Nu Skin Enterprises. “Jim adds extensive expertise...

2025-05-13 19:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-05-09 13:01:36 ET Corvus Pharmaceuticals Climbs 27% on Clinical Momentum and $31M Cash Infusion Corvus Pharmaceuticals Inc. ( CRVS ) rose nearly 27% by midday, lifting the PRISM Emerging Pharmaceuticals Index following the release of its Q1 2025 earnings . The company...

2025-05-08 18:11:22 ET More on Nu Skin Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript Nu Skin Enterprises, Inc. 2025 Q1 - Results - Earnings Call Presentation Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript Nu Skin Revenue o...

2025-05-08 18:10:50 ET Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Conference Call May 08, 2025, 05:00 PM ET Company Participants B.G. Hunt - Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer ...